TD Cowen reaffirmed a Buy rating on Boston Scientific Corporation (NYSE:BSX) and named it their “Best Idea for 2026” with a $115 price target. The company is considered one of the best healthcare AI stocks to buy now. Boston Scientific is projected to maintain double-digit organic revenue growth into 2026. Key drivers include products like Farapulse and Watchman. The company participated in the 7th Annual Wolfe Research Healthcare Conference, highlighting strong adoption of the Farapulse pulsed field ablation system. Boston Scientific uses AI in various medical applications, including cardiology and endoscopy.

Read more at Yahoo Finance: Is Boston Scientific (BSX) One of the Best Healthcare AI Stocks to Buy Now?